Cohance Lifesciences Limited
COHANCE
株式のランク
#6362
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
株価
$5.06
時価総額
$1.93B
変化（1日）
-1.34%
変化（1年）
-57.36%
国
IN
取引 Cohance Lifesciences Limited (COHANCE)
カテゴリー
Healthcare
の時価総額 Cohance Lifesciences Limited(COHANCE)
時価総額: $1.93B
October 2026時点で、Cohance Lifesciences Limited の時価総額は $1.93B です。これは、当社のデータによると、Cohance Lifesciences Limited が世界で6362nd番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
Cohance Lifesciences Limited の時価総額の履歴（2020 から 2026 まで）
